<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>239555</rcn>
  <id>101071140</id>
  <acronym>MUTAVAC</acronym>
  <teaser>The successful application of immune checkpoints inhibitors has modified the therapeutic strategies in several cancers but only 30% of patients will respond optimally to these therapies. One of the reasons for the failure of these therapies is the resistance of cancer stem...</teaser>
  <objective>The successful application of immune checkpoints inhibitors has modified the therapeutic strategies in several cancers but only 30% of patients will respond optimally to these therapies. One of the reasons for the failure of these therapies is the resistance of cancer stem cells (CSCs) leading to relapses long after the initial treatment. These cells are also resistant to conventional therapies via their quiescence and there are no targeted therapies available against them. The ambition of IPSIRIUS, a French biotechnology company, spinoff of INSERM and Paris Saclay University is to develop active cancer immunotherapy products based on the revolutionary induced pluripotent stem cell (iPSC) technology. IPSIRIUS developed first IPVAC, with the aim of leveraging patients immune system against a large panel of cancer antigens which are shared between iPSC and CSCs. With IPVAC, IPSIRIUS is developing a ground-breaking technology, having resolved all technical issues limiting cell-based therapies used for cancer. IPVAC is a safe, allogenic, off-the-shelf therapy, highly scalable using a versatile technology. This cell-based vaccination strategy showed efficacy in prophylactic and therapeutic settings against aggressive solid cancers with stemness features. The overall goal of the MUTAVAC project is i) to uncover the mechanisms of action of IPVAC, ii) to generate a highly immunogenic version of IPVAC, and iii) to design robust in vitro immunogenicity tests to predict immunogenicity of IPVAC and IPVAC-Mut in humans. With MUTAVAC project, IPSIRIUS will i) strengthen the scientific data on IPVAC to prepare its clinical development and leading to the open access publications and patents, ii) define a personalised medicine to propose efficient therapeutic cancer vaccine in patients with all HLA groups, iii) identify new targets for future cancer therapies, and iv) develop a technological platform to facilitate the development of the next-generation of cell therapies.</objective>
  <title>Targeting cancer with mutanome based stem cell vaccine</title>
  <keywords>induced pluripotent stem cells, cancer stem cells, immunotherapy vaccine</keywords>
  <totalCost>1809500</totalCost>
  <ecMaxContribution>1782000</ecMaxContribution>
  <startDate>2022-10-01</startDate>
  <endDate>2025-09-30</endDate>
  <ecSignatureDate>2022-06-17</ecSignatureDate>
  <duration>36</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/101071140</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-01-03 10:47:16</sourceUpdateDate>
  <contentCreationDate readOnly="true">2022-08-10 17:31:12</contentCreationDate>
  <contentUpdateDate>2025-09-01 22:54:52</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-03 09:43:26</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>436709</rcn>
        <id>436709-an-off-the-shelf-anti-cancer-vaccine</id>
        <title>An off-the-shelf anti-cancer vaccine</title>
        <contentUpdateDate>2022-10-31 17:44:03</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55324</rcn>
        <title>HORIZON-EIC-2021-PATHFINDERCHALLENGES-01</title>
        <identifier>HORIZON-EIC-2021-PATHFINDERCHALLENGES-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55324</rcn>
        <title>HORIZON-EIC-2021-PATHFINDERCHALLENGES-01</title>
        <identifier>HORIZON-EIC-2021-PATHFINDERCHALLENGES-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="1782000" terminated="false" sme="true" netEcContribution="1782000" totalCost="1809500" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1975319</rcn>
        <id>889768876</id>
        <vatNumber>FR73843629940</vatNumber>
        <legalName>IPSIRIUS</legalName>
        <address>
          <street>23 RUE PIERRE NICOLE</street>
          <city>Paris</city>
          <postalCode>75005</postalCode>
          <country>FR</country>
          <geolocation>48.8407717,2.3395907</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Paris</name>
              <rcn>258740225</rcn>
              <nutsCode>FR101</nutsCode>
              <parents>
                <region>
                  <name>Ile-de-France</name>
                  <rcn>258740264</rcn>
                  <nutsCode>FR10</nutsCode>
                  <parents>
                    <region>
                      <name>Ile-de-France</name>
                      <rcn>258742824</rcn>
                      <nutsCode>FR1</nutsCode>
                      <parents>
                        <region>
                          <name>France</name>
                          <rcn>258902568</rcn>
                          <nutsCode>FR</nutsCode>
                          <euCode>FR</euCode>
                          <isoCode>FR</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>France</name>
              <rcn>258902568</rcn>
              <nutsCode>FR</nutsCode>
              <euCode>FR</euCode>
              <isoCode>FR</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705895</rcn>
        <id>HORIZON_HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03</id>
        <code>HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Emerging Technologies in Cell and Gene therapy</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454377</code>
              <title>Market research</title>
              <displayCode readOnly="true">/Market research</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43449507</code>
              <title>Artificial organs</title>
              <displayCode readOnly="true">/Artificial organs</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454386</code>
              <title>Market-creating innovation</title>
              <displayCode readOnly="true">/Market-creating innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450539</code>
              <title>Competitor analysis</title>
              <displayCode readOnly="true">/Competitor analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450122</code>
              <title>Cell biology and molecular transport mechanisms</title>
              <displayCode readOnly="true">/Cell biology and molecular transport mechanisms</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/31101684</code>
              <title>Exploitation of results</title>
              <displayCode readOnly="true">/Exploitation of results</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450863</code>
              <title>Data markets</title>
              <displayCode readOnly="true">/Data markets</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450029</code>
              <title>Business model innovation</title>
              <displayCode readOnly="true">/Business model innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454362</code>
              <title>Market analysis</title>
              <displayCode readOnly="true">/Market analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451698</code>
              <title>Entrepreneurship</title>
              <displayCode readOnly="true">/Entrepreneurship</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452664</code>
              <title>Gene therapy</title>
              <displayCode readOnly="true">/Gene therapy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450722</code>
              <title>Cost estimation / analysis</title>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457773</code>
              <title>Spin-off companies</title>
              <displayCode readOnly="true">/Spin-off companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450698</code>
              <title>Copyrights</title>
              <displayCode readOnly="true">/Copyrights</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454380</code>
              <title>Market studies</title>
              <displayCode readOnly="true">/Market studies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453822</code>
              <title>Investment readiness</title>
              <displayCode readOnly="true">/Investment readiness</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456744</code>
              <title>Risk analysis</title>
              <displayCode readOnly="true">/Risk analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457866</code>
              <title>Stem cell therapy</title>
              <displayCode readOnly="true">/Stem cell therapy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458169</code>
              <title>Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)</title>
              <displayCode readOnly="true">/Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452043</code>
              <title>Feasibility analysis</title>
              <displayCode readOnly="true">/Feasibility analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458205</code>
              <title>Technology transfer</title>
              <displayCode readOnly="true">/Technology transfer</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450536</code>
              <title>Competitiveness, innovation, research and development</title>
              <displayCode readOnly="true">/Competitiveness, innovation, research and development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458031</code>
              <title>Sustainable innovation</title>
              <displayCode readOnly="true">/Sustainable innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453435</code>
              <title>Incremental innovation</title>
              <displayCode readOnly="true">/Incremental innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458199</code>
              <title>Technology implementation</title>
              <displayCode readOnly="true">/Technology implementation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456591</code>
              <title>Regulatory framework for innovation</title>
              <displayCode readOnly="true">/Regulatory framework for innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452094</code>
              <title>Finance</title>
              <displayCode readOnly="true">/Finance</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457314</code>
              <title>Simulation engineering and modelling</title>
              <displayCode readOnly="true">/Simulation engineering and modelling</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454026</code>
              <title>Licensing</title>
              <displayCode readOnly="true">/Licensing</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450035</code>
              <title>Business plan</title>
              <displayCode readOnly="true">/Business plan</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450131</code>
              <title>Cell differentiation, physiology and dynamics</title>
              <displayCode readOnly="true">/Cell differentiation, physiology and dynamics</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458163</code>
              <title>Technological innovation</title>
              <displayCode readOnly="true">/Technological innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456414</code>
              <title>Public sector innovation</title>
              <displayCode readOnly="true">/Public sector innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453576</code>
              <title>Innovation management</title>
              <displayCode readOnly="true">/Innovation management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456567</code>
              <title>Regenerative medicine</title>
              <displayCode readOnly="true">/Regenerative medicine</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457863</code>
              <title>Stem cell biology</title>
              <displayCode readOnly="true">/Stem cell biology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451088</code>
              <title>Disruptive innovation</title>
              <displayCode readOnly="true">/Disruptive innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458196</code>
              <title>Technology evaluation</title>
              <displayCode readOnly="true">/Technology evaluation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458709</code>
              <title>Virology</title>
              <displayCode readOnly="true">/Virology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458364</code>
              <title>Trademarks</title>
              <displayCode readOnly="true">/Trademarks</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450158</code>
              <title>Certification, Verification, Validation, Technical Compliance, Standards</title>
              <displayCode readOnly="true">/Certification, Verification, Validation, Technical Compliance, Standards</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450017</code>
              <title>Business development</title>
              <displayCode readOnly="true">/Business development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452667</code>
              <title>Gene therapy, cell therapy, regenerative medicine</title>
              <displayCode readOnly="true">/Gene therapy, cell therapy, regenerative medicine</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450125</code>
              <title>Cell biology, Microbiology</title>
              <displayCode readOnly="true">/Cell biology, Microbiology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450962</code>
              <title>Design innovation</title>
              <displayCode readOnly="true">/Design innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457812</code>
              <title>Start-up companies</title>
              <displayCode readOnly="true">/Start-up companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458190</code>
              <title>Technology commercialisation</title>
              <displayCode readOnly="true">/Technology commercialisation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450128</code>
              <title>Cell cycle and division</title>
              <displayCode readOnly="true">/Cell cycle and division</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451250</code>
              <title>Economics of innovation</title>
              <displayCode readOnly="true">/Economics of innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456588</code>
              <title>Regulatory and Standardization</title>
              <displayCode readOnly="true">/Regulatory and Standardization</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451830</code>
              <title>Epigenetics and gene regulation</title>
              <displayCode readOnly="true">/Epigenetics and gene regulation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450134</code>
              <title>Cell genetics</title>
              <displayCode readOnly="true">/Cell genetics</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453837</code>
              <title>IPR management</title>
              <displayCode readOnly="true">/IPR management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43455622</code>
              <title>Patents</title>
              <displayCode readOnly="true">/Patents</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454866</code>
              <title>Morphology and functional imaging of cells</title>
              <displayCode readOnly="true">/Morphology and functional imaging of cells</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450005</code>
              <title>Business analysis</title>
              <displayCode readOnly="true">/Business analysis</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1070934</rcn>
        <id>101071140_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - MUTAVAC (Targeting cancer with mutanome based stem cell vaccine)</title>
        <teaser>The past two decades have seen major breakthroughs in the cancer research with discovery of targeted therapies and, notably, immunotherapies such as immune checkpoint inhibitors (ICIs) and CAR-Ts. However, there are major unmet medical needs in the therapy of advanced cancers...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2024-03-31 17:03:30</sourceUpdateDate>
        <contentUpdateDate>2024-04-01 14:08:18</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webItem source="corda" type="relatedResultAttachment">
              <language>en</language>
              <availableLanguages readOnly="true">en,any</availableLanguages>
              <uri>/docs/results/horizon/101071/101071140_PS/image-mutavac-eic.jpg</uri>
              <alternativeText>Mutavac programme</alternativeText>
              <mimetype readOnly="true">image/jpeg</mimetype>
              <size readOnly="true">47104</size>
            </webItem>
          </associations>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1049093</rcn>
        <id>101071140_1_DELIVHORIZON</id>
        <title>Public website and project logo</title>
        <description>Public website and project logo</description>
        <sourceUpdateDate>2024-02-23 03:31:32</sourceUpdateDate>
        <contentUpdateDate>2024-03-04 17:02:11</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/deliverable</code>
              <title>Project deliverable</title>
              <description>Result: Project deliverables</description>
              <displayCode readOnly="true">/Project deliverable</displayCode>
            </category>
            <category classification="deliverableType" type="isDeliveredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/DEC</code>
              <title>Websites, patent fillings, videos etc.</title>
              <displayCode readOnly="true">/Websites, patent fillings, videos etc.</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <webLink source="corda" represents="project" type="projectDeliverable">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <defaultLanguage>en</defaultLanguage>
              <id>cae3b083ca3b25ae7a475762ef472b0d</id>
              <physUrl><![CDATA[https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e501e2f42f&appId=PPGMS]]></physUrl>
            </webLink>
          </associations>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/643</code>
        <title>immunotherapy</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/immunology/immunotherapy</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/37/163</code>
        <title>cells technologies</title>
        <displayCode readOnly="true">/medical and health sciences/medical biotechnology/cells technologies</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC</code>
        <title>HORIZON EIC Grants</title>
        <description>HORIZON EIC Grants</description>
        <displayCode readOnly="true">/HORIZON EIC Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
